Skip to Main content Skip to Navigation
Journal articles

Matrix metalloproteinases as new targets in Alzheimer's disease: Opportunities and Challenges

Abstract : Although matrix metalloproteinases (MMPs) are implicated in the regulation of numerous physiological processes, evidences of their pathological roles have also been obtained in the last decades, making MMPs attractive therapeutic targets for several diseases. Recent discoveries of their involvement in central nervous system (CNS) disorders, and in particular in Alzheimer's disease (AD), have paved the way to consider MMP modulators as promising therapeutic strategies. Over the past few decades, diverse approaches have been undertaken in the design of
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03461436
Contributor : Santiago Rivera Connect in order to contact the contributor
Submitted on : Wednesday, December 1, 2021 - 12:49:01 PM
Last modification on : Wednesday, March 9, 2022 - 12:26:03 PM

Files

Final version.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : hal-03461436, version 1
  • ARXIV : 2112.01081

Citation

Pauline Zipfel, Christophe Rochais, Kévin Baranger, Santiago Rivera, Patrick Dallemagne. Matrix metalloproteinases as new targets in Alzheimer's disease: Opportunities and Challenges. Journal of Medicinal Chemistry, American Chemical Society, 2020. ⟨hal-03461436⟩

Share

Metrics

Record views

32

Files downloads

32